![FDA announces recall of platelet-reducing medication due to risk of clotting or other adverse cardiovascular outcomes FDA announces recall of platelet-reducing medication due to risk of clotting or other adverse cardiovascular outcomes](https://cardiovascularbusiness.com/sites/default/files/styles/top_stories/public/2022-05/screen_shot_2022-05-24_at_11.24.40_am.png.webp?itok=cecCZ20-)
FDA announces recall of platelet-reducing medication due to risk of clotting or other adverse cardiovascular outcomes
![FDA joins EU in seeking recall of certain Chinese-made valsartan products over potential cancer risk | Fierce Pharma FDA joins EU in seeking recall of certain Chinese-made valsartan products over potential cancer risk | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1531746198/fda1.jpg/fda1.jpg?VersionId=m.GEAsQBWOSOs09of9slVAiRIZZpoA0h)
FDA joins EU in seeking recall of certain Chinese-made valsartan products over potential cancer risk | Fierce Pharma
IMPORTANT Metformin Hydrochloride Extended Release Tablets, USP, 500 mg and 750 mg RECALL NOTICE Dear Member, Your health is imp
FDA Safety Alert: Teva Initiates Voluntary Nationwide Recall of Specific Lots of Fentanyl Buccal Tablets CII Due to a Labeling Error - Drugs.com
![Teva Initiates Voluntary Nationwide Recall of Specific Lots of FENTANYL Buccal Tablets CII Due to a Labeling Error | FDA Teva Initiates Voluntary Nationwide Recall of Specific Lots of FENTANYL Buccal Tablets CII Due to a Labeling Error | FDA](https://www.fda.gov/files/styles/recall_image_small/public/Image%201_270.jpg?itok=W3x9lGB-)
Teva Initiates Voluntary Nationwide Recall of Specific Lots of FENTANYL Buccal Tablets CII Due to a Labeling Error | FDA
Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of All Amlodipine/Valsartan Combination Tablet
![International Laboratories, LLC Issues Voluntary Nationwide Recall of One (1) Lot of Pravastatin Sodium Tablets USP, 40mg Packaged in Bottles of 30 Tablets Due to Mislabeling NDC # 54458-925-16; Lot # 115698A | FDA International Laboratories, LLC Issues Voluntary Nationwide Recall of One (1) Lot of Pravastatin Sodium Tablets USP, 40mg Packaged in Bottles of 30 Tablets Due to Mislabeling NDC # 54458-925-16; Lot # 115698A | FDA](https://www.fda.gov/files/styles/recall_image_small/public/Pravastatin%20Sodium%20Tablet%20USP%2040%20mg_0.jpg?itok=pahnrbiZ)
International Laboratories, LLC Issues Voluntary Nationwide Recall of One (1) Lot of Pravastatin Sodium Tablets USP, 40mg Packaged in Bottles of 30 Tablets Due to Mislabeling NDC # 54458-925-16; Lot # 115698A | FDA
![Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA](https://www.fda.gov/files/styles/recall_image_small/public/2_12.jpg?itok=TE3Ci_G3)
Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA
![Teva Pharmaceuticals USA, Inc., Issues Voluntary Nationwide Recall of Specific Lots of Fentanyl Buccal Tablets CII Because of Labeling Error | ONS Voice Teva Pharmaceuticals USA, Inc., Issues Voluntary Nationwide Recall of Specific Lots of Fentanyl Buccal Tablets CII Because of Labeling Error | ONS Voice](https://voice.ons.org/sites/default/files/2018-03/FDA-Update-700_11.jpg)
Teva Pharmaceuticals USA, Inc., Issues Voluntary Nationwide Recall of Specific Lots of Fentanyl Buccal Tablets CII Because of Labeling Error | ONS Voice
![Teva Pharmaceuticals USA, Inc. Initiates Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP 500 mg and 750 mg Due to Detection of N-Nitrosodimethylamine (NDMA) | FDA Teva Pharmaceuticals USA, Inc. Initiates Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP 500 mg and 750 mg Due to Detection of N-Nitrosodimethylamine (NDMA) | FDA](https://www.fda.gov/files/styles/recall_image_small/public/Image%203_39.jpg?itok=Dr_sOLFG)